AstraZeneca PLC Ordinary Shares (AZN)
EBITDA Growth
4.20%
Quarterly · Period ending:
AZN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported4.20%period ending
Latest reported4.20%period ending
AZN Quarterly EBITDA YoY % (5.05% → 4.20%)
Year-over-year change
High-resolution chart · PNG
AZN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -7.0305% | |
| 9.1586% | |
| 320.793% | |
| 1.5444% | |
| -2.2967% | |
| -73.6048% | |
| 89.2108% | |
| -49.8326% | |
| 46.0299% | |
| 87.0321% | |
| -22.8426% | |
| 10.9936% | |
| -61.9527% | |
| 5.845% | |
| -54.8682% | |
| -9.2583% | |
| 0.2414% | |
| 0.2414% | |
| 40.0791% | |
| 19.5659% | |
| 501.6636% | |
| 12.9592% | |
| -17.9348% | |
| 10.3948% | |
| -79.3826% | |
| 9.816% | |
| -3.4621% | |
| 14.0403% | |
| 5.05% | |
| 5.05% |